Research Focus

Former Employee. Medicine; Clinical Research Coordinator

Recent additions – View all

1. Nomogram for predicting risk of cancer therapy-related cardiac dysfunction in patients with human epidermal growth factor receptor 2-positive breast cancer

   Journal Article

   Yu, A. F.; Lin, I. H.; Jorgensen, J.; Copeland-Halperin, R.; Feldman, S.; Ibtida, I.; Assefa, A.; Johnson, M. N.; Dang, C. T.; Liu, J. E.; more...
   Journal of the American Heart Association (2023)

   Fulltext@MSK | Save
2. Cardiac safety of reduced surveillance for cancer therapy related cardiac dysfunction in patients with breast cancer treated with HER2-targeted therapy

   Meeting Abstract

   Yu, A. F.; Dang, C. T.; Jorgensen, J.; Moskowitz, C. S.; Wallins, J.; DeFusco, P. A.; Oligino, E.; Oeffinger, K. C.; Liu, J.; Steingart, R.
   Journal of Clinical Oncology (2023)

   Fulltext@MSK | Save
3. Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy

   Journal Article

   Yu, A. F.; Dang, C. T.; Jorgensen, J.; Moskowitz, C. S.; DeFusco, P.; Oligino, E.; Oeffinger, K. C.; Liu, J. E.; Steingart, R. M.
   Cardio-Oncology (2023)

   Fulltext@MSK | Save